TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE B-

NCT05913609: Safety and Effectiveness of the Yaari Extractor for Management of Shoulder Dystocia

Sponsor: FetalEase Ltd. · Phase: PHASE2 · Area: CARDIOLOGY_METABOLIC · Target Enrollment: 80 pts

Competing Trials Overlap

5 Active Trials

Excess Burn Exposure

$830,000

Rescue Site Savings

+$531,200

Unlock Full NCT05913609 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT05913609 Rescue Dossier →